GHP Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41K Hold
25
﹤0.01% 942
2026
Q1
$2.95K Hold
25
﹤0.01% 968
2025
Q4
$4.1K Hold
25
﹤0.01% 848
2025
Q3
$3.34K Hold
25
﹤0.01% 832
2025
Q2
$3.11K Hold
25
﹤0.01% 845
2025
Q1
$3.18K Hold
25
﹤0.01% 829
2024
Q4
$3.6K Hold
25
﹤0.01% 845
2024
Q3
$3.72K Hold
25
﹤0.01% 837
2024
Q2
$3.15K Hold
25
﹤0.01% 816
2024
Q1
$4.6K Hold
25
﹤0.01% 716
2023
Q4
$4.5K Hold
25
﹤0.01% 717
2023
Q3
$3.82K Buy
+25
New +$4.09K ﹤0.01% 806

Other funds holding RGEN

GHP Investment Advisors's RGEN Position: Q2 2026 in Review

GHP Investment Advisors held its Repligen (RGEN) position steady in Q2 2026 at 25 shares worth $3.41K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

GHP Investment Advisors first reported a position in RGEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.6K in Q1 2024. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • GHP Investment Advisors held 25 shares of Repligen worth $3.41K as of Q2 2026.
  • GHP Investment Advisors left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #942 holding.
  • GHP Investment Advisors first reported a position in Repligen in Q3 2023 and has held it in 12 quarters since.
  • GHP Investment Advisors's Repligen position peaked at $4.6K in Q1 2024.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.